Skip to main content
. Author manuscript; available in PMC: 2017 Jun 13.
Published in final edited form as: Alzheimers Dement. 2015 Jun;11(6):e1–120. doi: 10.1016/j.jalz.2014.11.001

Fig. 4.

Fig. 4

AD drug development. Black arrows show the phases of drug development; the brick-colored arrows show the ADNI biomarkers that could be used in that stage. Reproduced with permission from Ref [37].